|
PVSRIPO, or PVS-RIPO, is the name of a modified polio virus that has recently shown promise for treating cancer. It is the focus of clinical trials being conducted at Duke University. A 2014 review article in the peer-reviewed journal ''Cancer'' by some of the main researchers on PVSRIPO concluded that A website at Duke University describes many of properties of PVSRIPO, and historical background about using viruses to oppose cancer.〔(【引用サイトリンク】url=http://www.cancer.duke.edu/btc/modules/Research3/index.php?id=41 )〕 According to that website, The potential value of PVSRIPO was the focus of a 2015 story on ''Newsmax'', and a 2015 story on ''60 Minutes. ==See also== * Oncolytic virus 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「PVSRIPO」の詳細全文を読む スポンサード リンク
|